Answers are grounded in this paper and cite their sources.
BACKGROUND AND OBJECTIVES: Peripheral neuropathy is a common manifestation of systemic and nonsystemic vasculitides; however, there is limited literature on vasculitic myopathy. We aim to describe the clinical, laboratory, and pathologic characteristics and treatment outcomes of vasculitic myopathy. METHODS: A retrospective chart review of patients with a diagnosis of vasculitis and myopathy (1980-2022) was performed. Patients were included with either biopsy-proven vasculitic myopathy or biopsy-proven vasculitis (of nonmuscle tissue) and concomitant active myopathy after excluding alternative causes. All muscle biopsy slides were reviewed, and additional immunohistochemistry studies were performed. RESULTS: T cells, with complement deposition on blood vessels in some. Twenty-four patients improved with immunotherapy, and only 3 patients relapsed. Seven patients died during the study period, 1 from vasculitis complications. Probability of survival at 1 and 5 years was 96% and 84%, respectively. DISCUSSION: Myopathy can be the initial manifestation of a primary or secondary systemic vasculitis or may occur as a nonsystemic form. Most patients present with proximal predominant weakness with normal CK and elevated aldolase levels. Patients usually respond well to immunotherapy.
No takes yet. Share an insight, caveat, or question.
Pinto et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: